KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Cellectis S.A. stock price down 0.400% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 23, 2024 Loss -4.95% PDF

The Cellectis S.A. stock price fell by -0.400% on the last day (Thursday, 25th Apr 2024) from $2.50 to $2.49. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.85% from a day low at $2.47 to a day high of $2.61. The price has fallen in 7 of the last 10 days and is down by -11.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -24 thousand shares and in total, 15 thousand shares were bought and sold for approximately $36.60 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.78% during the next 3 months and, with a 90% probability hold a price between $1.92 and $2.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLLS Signals & Forecast

There are few to no technical positive signals at the moment. The Cellectis S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.53 and $2.59. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -11.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cellectis S.A. stock

Cellectis S.A. finds support from accumulated volume at $2.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.145 between high and low, or 5.85%. For the last week the stock has had daily average volatility of 4.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLLS) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Cellectis S.A. to open at $2.52, and during the day (based on 14 day Average True Range), to move between $2.33 and $2.65, which gives a possible trading interval of +/-$0.159 (+/-6.39%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 12.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.48 (0.40%) than the resistance at $2.55 (2.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cellectis S.A. will release earnings BMO on Thursday, May 02, 2024. We will update the financials statements for Cellectis S.A., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.13% in the first trading day after earnings release.

Is Cellectis S.A. stock A Buy?

Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.838 Sell Candidate Unchanged

Predicted Opening Price for Cellectis S.A. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$2.52 ( 1.40%) $2.49

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.67 7.20 %
R2 2.61 4.99 %
R1 2.58 3.62 %
Current price: 2.49
Support S1 2.47 -0.82 %
S2 2.44 -2.19 %
S3 2.38 -4.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.72 9.24 %
R2 2.69 8.03 %
R1 2.55 2.41 %
Current price 2.49
Support S1 2.48 -0.402%
S2 2.45 -1.61%
S3 2.41 -3.21%

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the Apr 25, 2024, the price of an Cellectis S.A. (CLLS) share was $2.49.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $3.77 and the 52-week low is $0.96.

What is the market capitalization of Cellectis S.A. Stock?
As of the Apr 25, 2024, the market capitalization of Cellectis S.A. is 178.66M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is May 02, 2024.
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT